Skip to main content
padlock icon - secure page this page is secure

SCREENING FOR HIV-ASSOCIATED DISTAL-SYMMETRIC POLYNEUROPATHY IN CDC-CLASSIFICATION STAGES 1, 2 AND 3

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

OBJECTIVES—A total of 670 patients were screened for distal symmetric HIV-associated polyneuropathy during CDC stages 1–3 and its correlation to immunological deterioration. MATERIAL AND METHODS—Clinical examinations of 670 patients admitted to the neurological outpatient clinic at the Department of Neurology, University of Munster. Neurophysiological investigations were performed on the sural and peroneal nerve for detection of axonal and myelin lesion. RESULTS—Clinical examination proved progressive clinical signs and symptoms indicating distal symmetric polyneuropathy from CDC 1 (32%) to CDC 3 (55%). At least one neurophysiological result was impaired in CDC 1 in 25% and in CDC 3 in 45%. Significant correlation between neurophysiological changes and CDC 4(+)-cells and beta-microglobuline were detected for stage CDC 3 C. CONCLUSION—Results show stage related prevalence of distal symmetric polyneuropathy already in early stages. In late stages of HIV-infection prevalence of distal symmetric polyneuropathy seems to be directly correlated to immunodeficiency syndrome. The pathogenesis of distal symmetric polyneuropathy during HIV-infection is up to now incompletely understood, but results indicate a clear dependency between progressive immunological dysfunction and neuropathy. High active antiretroviral therapy in patients suffering from distal symmetric polyneuropathy is a main topic of future studies.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Abstract

Affiliations: Acta Neurologica Scandinavica 101: 183–187, 2000. Reprinted with permission from Munksgaard International Publishers, Ltd.

Publication date: December 1, 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more